Skip to content

Olivier Gryson

  • Home
  • Pharma Marketing in the Age of AI Search
  • Glossary
  • Contact
  • About
Olivier Gryson

Pharma Marketing in
the Age of AI Search

Pharma Marketing in the Age of AI Search is available at Amazon.com

A practical guide to winning visibility, trust, and relevance in a search- and AI-driven healthcare world

Pharma Marketing in the Age of AI Search is available at Amazon.
  • How to Build an Unbranded Disease Education Page That Ranks in AI Search

    May 30, 2026

    AI systems favour content that is factual, neutral, and expertly attributed. That description fits unbranded disease education perfectly — and branded pharma content almost never. This guide gives pharma teams a complete, compliant build process for disease education pages that get cited in AI-generated answers.

    Read more


  • Pharma GEO: Building Knowledge Graphs That AI Systems Trust

    May 25, 2026

    Pharma GEO: Building Knowledge Graphs That AI Systems Trust What Is Generative Engine Optimization (GEO) — and Why Does Pharma Need It Now? Generative Engine Optimization (GEO) is the practice of structuring digital content so that large language models (LLMs) — ChatGPT, Perplexity AI, Google Gemini, Microsoft Copilot — can find, understand, and cite it when…

    Read more


  • Digital Transformation in Pharma: How GEO Is Reshaping the Entire Organization

    May 6, 2026

    How GEO and AI search will transform marketing, medical affairs, MLR, regulatory, legal, and IT in pharma — and what each function must do now.

    Read more


  • Why Getting Found by AI Is a Marketing Problem, Not a Technical One — and Why Pharma Must Lead It

    May 1, 2026

    Generative Engine Optimization in pharma isn’t a technical fix — it’s a brand and medical affairs discipline. Learn what drives AI citations, who should own GEO, and how to act.

    Read more


  • The Pharma AI Search Visibility Audit: how to track LLM presence (when rank trackers don’t)

    January 26, 2026

    Search Console won’t give you a clean “AI Overviews” report. Yet your content can still shape AI answers and lose clicks without your rankings moving. This post lays out a pharma-safe audit you can run monthly: build a query set by audience (public vs HCP), capture where AI answers appear, track whether you’re cited, score…

    Read more


  • The Real Fight Against Health Misinformation Moves From Social Media To AI Search

    January 24, 2026

    For years, health misinformation has been blamed on social media algorithms that reward emotion over evidence. While that diagnosis remains valid, it is no longer sufficient. As patients and healthcare professionals increasingly rely on AI-mediated search for answers, the fight against misinformation is shifting upstream, from viral posts to systems that synthesize, weight, and surface…

    Read more


  • E-E-A-T in Pharma: Trustworthiness and HCP Content Visibility

    January 17, 2026

    Trustworthy HCP content is verifiable and maintained: clear author/reviewer, credible sources, and a visible update date. Keep it practical and neutral. And with AI drafts, don’t let “polished” writing lower vigilance—high volume plus good-looking text means MLR must be more skeptical, not less.

    Read more


  • E-E-A-T in Pharma: Authoritativeness and HCP Content Visibility

    January 12, 2026

    EEAT is no longer a “nice to have” in pharma content. If you want your HCP pages to show up in AI-driven search, you need to prove they’re built on real authority: credible authors, clear credentials, and references that stand up to scrutiny. This article breaks down practical ways to signal authoritativeness without falling into…

    Read more


  • Pharma Marketing E-E-A-T Checklist: Improve Trust and AI Visibility

    January 10, 2026

    In pharma, trust drives performance. This practical E-E-A-T checklist shows how to improve authorship, medical review, sourcing, and page structure in under an hour—so your content ranks better, reads clearly, and is more likely to be quoted in AI search results.

    Read more


1 2
Next Page

Published on: December 28, 2025
Last updated: May 30, 2026

© 2026 Olivier Gryson - Terms of Use and Privacy - Contact

Content on this website is provided for informational and thought-leadership purposes only. All examples, scenarios, and recommendations are illustrative and intended to stimulate discussion, not to provide medical, legal, regulatory, or compliance advice.

Any pharmaceutical activities must be conducted in accordance with applicable laws and regulations, relevant industry codes of practice (including those of EFPIA and IFPMA), and internal Medical, Legal, and Regulatory (MLR) review and approval processes. Responsibility for compliance remains with the reader and their organization.

  • Home
  • Pharma Marketing in the Age of AI Search
  • Glossary
  • Contact
  • About